T1	intervention 40 69	hypofractionated radiotherapy
T2	No-of-participants 449 452	989
T3	No-of-participants 456 460	1234
T4	eligibility 310 337	node-negative breast cancer
T5	outcome-Measure 946 967	local recurrence (LR)
T6	duration 990 998	12 years
T7	outcome 1092 1120	10-year cumulative incidence
T8	control 237 263	standard radiotherapy (RT)
T9	intervention-value 1125 1129	4.5%
T10	outcome 1134 1158	luminal A and basal-like
T11	intervention-value 1160 1164	7.9%
T12	outcome 1169 1178	luminal B
T13	intervention-value 1183 1188	16.9%
T14	outcome 1193 1214	HER-2 enriched tumors
